Blijlevens NMA - Search Results

1

BCR::ABL1 kinase domain mutation testing and clinical outcome in a nationwide chronic myeloid leukemia patient population.

Kockerols C, Valk PJM, Blijlevens NMA, Cornelissen JJ, Dinmohamed AG, Geelen I, Hoogendoorn M, Janssen JJWM, Daenen LGM, Reijden BAV, Westerweel PE. Kockerols C, et al. Among authors: blijlevens nma. Eur J Haematol. 2023 Dec;111(6):938-945. doi: 10.1111/ejh.14107. Epub 2023 Sep 20. Eur J Haematol. 2023. PMID: 37731314

2

Real-world costs of autologous and allogeneic stem cell transplantations for haematological diseases: a multicentre study.

Blommestein HM, Verelst SG, Huijgens PC, Blijlevens NM, Cornelissen JJ, Uyl-de Groot CA. Blommestein HM, et al. Ann Hematol. 2012 Dec;91(12):1945-52. doi: 10.1007/s00277-012-1530-2. Epub 2012 Aug 5. Ann Hematol. 2012. PMID: 22864761

3

Treatment, trial participation and survival in adult acute myeloid leukemia: a population-based study in the Netherlands, 1989-2012.

Dinmohamed AG, Visser O, van Norden Y, Blijlevens NM, Cornelissen JJ, Huls GA, Huijgens PC, Sonneveld P, van de Loosdrecht AA, Ossenkoppele GJ, Löwenberg B, Jongen-Lavrencic M. Dinmohamed AG, et al. Leukemia. 2016 Jan;30(1):24-31. doi: 10.1038/leu.2015.188. Epub 2015 Jul 17. Leukemia. 2016. PMID: 26183645

4

Successful Transfer of Umbilical Cord Blood CD34⁺ Hematopoietic Stem and Progenitor-derived NK Cells in Older Acute Myeloid Leukemia Patients.

Dolstra H, Roeven MWH, Spanholtz J, Hangalapura BN, Tordoir M, Maas F, Leenders M, Bohme F, Kok N, Trilsbeek C, Paardekooper J, van der Waart AB, Westerweel PE, Snijders TJF, Cornelissen J, Bos G, Pruijt HFM, de Graaf AO, van der Reijden BA, Jansen JH, van der Meer A, Huls G, Cany J, Preijers F, Blijlevens NMA, Schaap NM. Dolstra H, et al. Among authors: blijlevens nma. Clin Cancer Res. 2017 Aug 1;23(15):4107-4118. doi: 10.1158/1078-0432.CCR-16-2981. Epub 2017 Mar 9. Clin Cancer Res. 2017. PMID: 28280089 Clinical Trial.

5

The potential health gain and cost savings of improving adherence in chronic myeloid leukemia.

Ector GICG, Govers TM, Westerweel PE, Grutters JPC, Blijlevens NMA. Ector GICG, et al. Among authors: blijlevens nma. Leuk Lymphoma. 2019 Jun;60(6):1485-1492. doi: 10.1080/10428194.2018.1535113. Epub 2019 Jan 22. Leuk Lymphoma. 2019. PMID: 30668187

6

High-dose posaconazole for azole-resistant aspergillosis and other difficult-to-treat mould infections.

Schauwvlieghe AFAD, Buil JB, Verweij PE, Hoek RAS, Cornelissen JJ, Blijlevens NMA, Henriet SSV, Rijnders BJA, Brüggemann RJM. Schauwvlieghe AFAD, et al. Among authors: blijlevens nma. Mycoses. 2020 Feb;63(2):122-130. doi: 10.1111/myc.13028. Epub 2019 Dec 15. Mycoses. 2020. PMID: 31660650 Free PMC article.

7

The effectiveness of ibrutinib in chronic lymphocytic leukaemia: a nationwide, population-based study in the Netherlands.

van der Straten L, Levin MD, Visser O, Blijlevens NMA, Cornelissen JJ, Doorduijn JK, Kater AP, Dinmohamed AG. van der Straten L, et al. Among authors: blijlevens nma. Br J Haematol. 2020 Mar;188(6):e109-e112. doi: 10.1111/bjh.16391. Epub 2020 Jan 28. Br J Haematol. 2020. PMID: 31991479 Free article. No abstract available.

8

The Development of a Web-Based, Patient-Centered Intervention for Patients With Chronic Myeloid Leukemia (CMyLife): Design Thinking Development Approach.

Ector GI, Westerweel PE, Hermens RP, Braspenning KA, Heeren BC, Vinck OM, de Jong JJ, Janssen JJ, Blijlevens NM. Ector GI, et al. J Med Internet Res. 2020 May 15;22(5):e15895. doi: 10.2196/15895. J Med Internet Res. 2020. PMID: 32412424 Free PMC article.

9

Response and Adherence to Nilotinib in Daily practice (RAND study): an in-depth observational study of chronic myeloid leukemia patients treated with nilotinib.

Boons CCLM, Timmers L, Janssen JJWM, Westerweel PE, Blijlevens NMA, Smit WM, Bartelink IH, Wilschut JA, Swart EL, Hendrikse NH, Hugtenburg JG. Boons CCLM, et al. Among authors: blijlevens nma. Eur J Clin Pharmacol. 2020 Sep;76(9):1213-1226. doi: 10.1007/s00228-020-02910-3. Epub 2020 Jun 2. Eur J Clin Pharmacol. 2020. PMID: 32488333 Free PMC article.

10

Primary therapy and relative survival among elderly patients with chronic myeloid leukemia: a population-based study in the Netherlands, 1989-2017.

Ector GICG, Visser O, Westerweel PE, Janssen JJWM, Blijlevens NMA, Dinmohamed AG. Ector GICG, et al. Among authors: blijlevens nma. Leukemia. 2020 Dec;34(12):3408-3412. doi: 10.1038/s41375-020-0902-1. Epub 2020 Jun 8. Leukemia. 2020. PMID: 32513966 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

246 results

Search Page

Filters